Rifaximin-α in alcohol-associated liver disease

Lancet Gastroenterol Hepatol. 2023 Jun;8(6):495-497. doi: 10.1016/S2468-1253(23)00033-X. Epub 2023 Mar 6.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Hepatic Encephalopathy* / complications
  • Humans
  • Liver Cirrhosis / complications
  • Liver Diseases, Alcoholic* / complications
  • Liver Diseases, Alcoholic* / drug therapy
  • Rifaximin / therapeutic use

Substances

  • Rifaximin